Toxoplasmosis Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 38
Price : Single User: US $ 2500  US $ 2000 Corporate User: US $ 7500  US $ 5625
Inquire Before Buying
This report is available at upto 25% Discount till 02 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Toxoplasmosis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, "Toxoplasmosis Global Clinical Trials Review, H2, 2016" provides an overview of Toxoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Toxoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

This report is available at upto 25% Discount till 02 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Toxoplasmosis Global Clinical Trials Review, H2, 2016

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Toxoplasmosis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 35
Abbreviations 35
Definitions 35
Research Methodology 36
Secondary Research 36
About GlobalData 37
Contact Us 37
Disclaimer 37
Source 38

List of Tables
Toxoplasmosis Therapeutics, Global, Clinical Trials by Region, 2016* 5
Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Toxoplasmosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Toxoplasmosis Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9
Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Toxoplasmosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2016* 18
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 19
Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 23
Toxoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Toxoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures
Toxoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 19
Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 23
Toxoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Toxoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 36
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Arterial Calcification Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 44
    GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Calcification. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, e......
  • Arterial Stiffness Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 69
    GlobalData's clinical trial report, "Arterial Stiffness Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points st......
  • Arterial Thrombosis Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 54
    GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points......
  • Arteriosclerosis Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 509
    GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H1, 2017" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status a......
  • Arteriovenous Fistula Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 54
    GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2017" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end ......
  • Artery Stenosis Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 73
    GlobalData's clinical trial report, "Artery Stenosis Global Clinical Trials Review, H1, 2017" provides an overview of Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and ......
  • Arthralgia Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 62
    GlobalData's clinical trial report, "Arthralgia Global Clinical Trials Review, H1, 2017" provides an overview of Arthralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. R......
  • Articular Cartilage Defect Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 61
    GlobalData's clinical trial report, "Articular Cartilage Defect Global Clinical Trials Review, H1, 2017" provides an overview of Articular Cartilage Defect clinical trials scenario. This report provides top line data relating to the clinical trials on Articular Cartilage Defect. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, tri......
  • Ascites Global Clinical Trials Review, H1, 2017
    Published: 26-Apr-2017        Price: US 2500 Onwards        Pages: 87
    GlobalData's clinical trial report, "Ascites Global Clinical Trials Review, H1, 2017" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report als......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs